In oncology and neurology the 18 F-radiolabeled glucose analogue 2-deoxy-2- 
act as a biomarker of glucose metabolism and as such has found widespread use in oncology and neurology, both in clinic and in research. 2 When injected into the human body, it preferentially accumulates in tissue that exhibit an increase in glycolysis, e.g., cancer cells. Conversely, diminished glucose consumption due to neuronal cell death in the brain inflicted by neurodegenerative disorders, e.g., Alzheimer's disease, can also indirectly be probed using [ 18 F]FDG. However, despite its prominent role, one major drawback associated with using [ 18 F]FDG is that it suffers from poor tissue selectivity when distinguishing between malignant cells and benign cells that have a high metabolic rate, such as certain cells associated with inflammation or infection. 3 Furthermore, since [ 18 F]FDG is a metabolic imaging agent it is not sufficiently capable of detecting tumors found in most prostate cancers, bronchoalveolar-cell carcinoma or renal-cell carcinoma due to the fact that their metabolic rate is relatively low and therefore indistinguishable from normal tissue. 4 Consequently, there is a great need for new PET tracers that exhibit both high affinity and selectivity towards a particular biomolecular target. In recent years, the concept of employing [ 18 F]FDG as a prosthetic group for the 18 F-radiolabeling of ligands with defined molecular targets in vivo has received considerable attention. 5 The rationale is that glycoconjugates (e.g., glycopeptides, glycoproteins) in general exhibit improved pharmacokinetic properties such as increased in vivo kinetics, higher metabolic stability and faster blood clearance compared to their non-glycosylated counterparts. 6 Furthermore, the relatively long half-life of 18 F (t 1/2 = 109.8 min) provides a sufficient amount of time to perform multi-step radiosynthesis followed by a subsequent PET investigation.
Several methods have been employed for the ligation of [ 18 F]FDG to a diverse set of ligands, for instance (i) via oxime formation, 7 (ii) chemoenzymatic approaches 8 as well as using (iii) thiol-selective S-glycosylation. 9 More importantly, one of the most established methods is by means of the CuAAC click reaction 10,11 which allows for a wide substrate scope using mild conditions. 12 Accordingly, in 2009, Maschauer et al., 13 reported the synthesis of a set of 2-O-trifluoromethanesulfonyl-D-mannopyranosides, i.e., precursors of [ 18 F]FDG analogs, that were equipped with either a a-1-O-propargyl (10a), a-1-O-(2-azido)ethyl (6a), a-or b-azido aglycons (16a and 16b respectively, Scheme 1).
In their study, only minor amounts of the a-configured precursors were radiolabeled (r14% radiochemical yield (RCY)) which rendered them inapplicable for PET. In contrast, the b-azide precursor (16b) gave a significantly higher RCY (71%) indicating that the b-anomeric configuration is a key criterion for a successful 18 F-radiolabelling. Ideally, a spacer between the FDG unit and the attached click functional group is desired to prevent any potential steric interference between the FDG unit and the ligand to which it will be attached. In fact, it has been shown that glucose derivatives bearing an anomeric 1,2,3-triazole, generated from the corresponding glucosyl azide, lack two key properties of [ 18 F]FDG, i.e., trapping via O-6 phosphorylation and cell uptake via GLUT-1 transporters. 20 This effect is most likely caused by the close proximity of the triazole. Moreover, ideally, in order to be able to radiolabel the full set of available click-enabled ligands, both azide-and alkyne equipped [ In this work, we report the detailed synthesis of the CuAAC clickable b-configured [ 
Results and discussion
Since the fluorination step required to obtain the b-configured
, is accompanied by an S N 2 inversion, the triflate precursors (6, 10) are by necessity b-D-mannopyranosides.
Unfortunately, b-D-mannopyranosides are well-known to be challenging to synthesize due to the inherently strong preference of conventional mannosyl donors to form a-D-mannopyranosides. This is a result of the simultaneous occurrence of both the a-directing anomeric effect and repulsion between the axial C-2 substituent and the approaching nucleophile. 21 Moreover, neighboring group participation of a 2-acyl mannosyl donor View Article Online also leads to a-mannopyranosides. Fortunately, several ingenious synthetic approaches to circumvent these obstacles have already been devised. A particularly elegant approach was developed by the Danishefsky group during the 1990's, where epoxidation of per-benzylated D-glucal using DMDO, conveniently provided the corresponding 1,2-a-anhydrosugar that subsequently during glycosylation stereoselectively produced the corresponding b-D-glucosideand simultaneously generated an unprotected hydroxyl group in the 2-position. Subsequent epimerization of this site, following an oxidation-reduction sequence generated the b-D-mannopyranoside. 22 In this report we employ a similar synthetic approach which is depicted in Scheme 2. The choosen route requires access to multi-gram quantities of 1,2-anhydrosugar 2a from tri-acetyl-Dglucal 1. While this transformation is commonly achieved using a dilute solution of DMDO in acetone, 23 performing this reaction on a large scale poses several practical issues. For instance, the DMDO solution has to be kept rigorously dry, only dilute solutions can be produced (ca. 0.1 M) and furthermore, the scale-up of organic peroxy compounds is potentially hazardous. To circumvent these drawbacks, the Dondoni group, in 2006, developed an epoxidation method for glycals where DMDO is formed in situ from a biphasic buffered solution containing oxone, acetone, satd. NaHCO 3 and DCM. 24 This protocol was further elaborated on by Lafont et al. in 2011 by the addition of the phase transfer catalyst, tetrabutylammonium hydrogen sulphate (TBAHSO 4 ) that significantly increased the reaction speed as well as the reproducibility. 25 By employing the oxoneacetone-TBAHSO 4 epoxidation protocol, we conveniently prepared the 1,2-anhydrosugar 2a which was then directly used in the subsequent glycosylation. The glycosylation of 2-chloroethanol or propargyl alcohol, promoted by ZnCl 2 in DCM, provided the corresponding b-D-glucosides 3 and 8 in 39% and 29%, respectively over two steps. The predominant by-product formed was the corresponding 1,2-diol hydrolysis product. Converting the 2-chloroethyl glucoside 3 to the corresponding 2-azidoethyl glucoside 4 proved to be a major challenge. Standard conditions for azidation, i.e., NaN 3 in DMF at elevated temperatures (80 1C or 110 1C), with or without the additives TBAI or TBAB, consistently resulted in a complex mixture of products due to acetate migration to the unprotected 2-OH, whereas no reaction occurred at ambient temperature. We therefore reasoned that installing a better leaving group might make the reaction proceed more smoothly and thus avoid the accompanying acetate migration. This was realized by converting the 2-chloro compound 3 to the corresponding iodo compound by means of the classical Finkelstein reaction utilizing NaI (2 eq.) in acetone at 70 1C for 48 h. The azidation of the iodoethyl glucoside using NaN 3 in DMF now proceeded cleanly at ambient temperature to afford the azidoethyl glucoside 4 in good yield (77%) over two steps. Next, we decided to use the nitrite-mediated Lattrell-Dax inversion for the pending epimerization. The Lattrell-Dax inversion has been extensively studied by the Ramström group 26 who concluded that the inversion proceeds reliably -and even stereospecifically -if and only if a vicinal equatorial ester is present. This criterion is suitably met for the glucosides 4 and 8. Standard triflation of glucoside 4 using triflic anhydride followed by inversion using TBANO 2 in toluene at ambient temperature over night yielded the b-D-mannopyranosides 5 and 9 cleanly albeit in a moderate yield of 46% and 48% respectively. The b-anomeric configuration was confirmed by evaluating the J C-1,H-1 coupling constant in a coupled 28 At first, the reaction was run in DCM at À25 1C to rt over night to give the fluorosugars 7 and 11 in 31% and 19% respectively. The poor yield rendered us to instead perform the reaction in diglyme at 100 1C for 10 min which afforded the fluorosugars 7 and 11 in a significantly increased yield of 66% and 35% respectively. The fluorination proceeded as expected with inversion of configuration, as proven by the characteristic J H-1,H-2 coupling constant of 7.6 Hz for 7 and 7.7 Hz for 11, confirming the gluco-configuration. Furthermore, 1D To test our hypothesis that a b-configured FDG precursor is radiolabeled to a greater extent than its a-anomeric counterpart, we decided to synthesize the a-FDGs reported by Maschauer et al. to make a direct side-by-side comparison using the same 18 F-fluorination set-up. On closer inspection of our devised synthetic route to the b-FDGs we realized that since the epoxidation step is only moderately stereoselective on acetylated glycals (a/b approx., 7 : 1), 24 as a consequence, the minor b-1,2-anhydrosugar (2b) would then upon glycosylation stereoselectively be ringopened to give the sought a-D-mannopyranosides, 4a and 8a, with the second hydroxyl group exposed. As predicted, the glycosylations outlined in Scheme 3 resulted in a diastereomeric mixture of the glycosides 4 and 4a, and 8 and 8a, (dr B 9 : 1 gluco/manno in both cases) that were separated using preparative HPLC. Spectroscopic data for the a-mannopyranosides was in good agreement with the data reported by Maschauer et al.
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Triflation or fluorination (vide supra) of the isolated a-mannopyranosides then furnished the required precursors (6a and 10a) and the a-configured FDGs (7a and 11a) respectively.
F-Radiolabeling
18 F was produced using the 18 O(p,n) 18 F reaction using a scanditronix MC-17 cyclotron. The water was transported to the hot cell and trapped on a QMA which was flushed with MeCN.
[ 18 F]Fluoride was eluted using a kryptofix 2.2.2/K 2 CO 3 solution.
After azeotropic distillation with MeCN the precursor (6, 6a, 10 or 10a) in dry MeCN was added to the vial which was heated to 85 1C for 30 minutes. After the reaction was finished, an aliquot was taken and analysed by radio-HPLC to determine the non-isolated RCY of the reaction (Table 1) . Both b-mannopyranosides 6 and 10 performed well under these conditions and gave RCY of 77 AE 2% and 88 AE 5% for [ 18 F]7 and [ 18 F]11, respectively (n = 2 for both compounds) (Scheme 4). Unfortunately the a-precursors gave no results (0% RCY) using these conditions as only unreacted 18 F À could be identified using analytical radio-HPLC. ‡ 
